Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report

We report the first successful treatment with the IL-1 receptor antagonist anakinra, in association with the most promising and available antiviral therapy, of a severe case of novel coronavirus disease 2019 (COVID-19). We describe the diagnosis, clinical course, and management of the case, includin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Marco Franzetti, Ugo Pozzetti, Manuela Carugati, Alessandro Pandolfo, Chiara Molteni, Paolo Faccioli, Gioacchino Castaldo, Ernesto Longoni, Valentina Ormas, Enrico Iemoli, Stefania Piconi
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020-08-01
Colecção:International Journal of Infectious Diseases
Assuntos:
Novel coronavirus disease 2019 (COVID-19)
Cytokine-release syndrome
Interleukin-1 receptor antagonist
Anakinra
Remdesivir
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S120197122030357X
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados